RecruitingNCT05233527
Novosyn® Quick in Patients Undergoing Episiotomy Closure
Observational, Retrospective, Monocentric Clinical Study on the Safety of Novosyn® Quick in Women With a Spontaneous Vaginal Delivery Who Required an Indicated Episiotomy
Sponsor
Aesculap AG
Enrollment
300 participants
Start Date
May 9, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Retrospective, monocentric clinical study on the clinical performance of Novosyn® Quick in patients undergoing episiotomy closure.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria1
- Women who underwent an indicated episiotomy between January 2020 - December 2020 at the Hospital General de Catalunya (Sant Cugat del Vallès, Spain) and received Novosyn® Quick
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREEpisiotomy Closure
indicated episiotomy with Novosyn® Quick after spontaneous vaginal delivery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05233527